Tivozanib reduced adhesion of these cells to collagen I, concomitant with suppression of intercellular adhesion molecule-1 (ICAM-1) (Fig. 4E–G), a cell surface adhesion molecule that mediates tumour cell binding to the mesothelium and enhances tumour invasion42, 43. This evidence concerns the gene ICAM1 and neoplasm.